.png){kind=icon}
返回
J
Jiuwei Cui
The First Hospital of Jilin University
58H指数
638论文数
1.6W被引数
收录论文 243
发表时间
.png){kind=icon}
Mitochondria-specific targeting of noncanonical EGR1 ntmRNA-coordinated mitophagy receptor BNIP3 homodimerization disrupts mitochondrial metabolism and suppresses hepatocellular carcinoma growth in vitro and in vivo线粒体特异性靶向非经典EGR1 ntmRNA协调的线粒体自噬受体BNIP3同源二聚化破坏线粒体代谢并抑制肝细胞癌在体内外生长.png)
Theranostics.png)
TheranosticsIF13.3
PREAI
.png){kind=icon}
分享.png){kind=icon}
收藏Efficacy and safety of limertinib versus gefitinib as first-line treatment for locally advanced or metastatic non-small-cell lung cancer with EGFR-sensitising mutation: a randomised, double-blind, double-dummy, phase 3 trial利美ertenib相较于吉非替尼，作为携带EGFR敏感突变局部晚期或转移性非小细胞肺癌的一线治疗的疗效与安全性：一项随机、双盲、双模拟、III期临床试验
PREAI
分享收藏A Patient-Centric, Open-Label, Multicenter, Phase II Study of Lorlatinib Monotherapy in the First-Line Treatment of Patients With locally Advanced or Metastatic ALK-Positive Non-Small Cell Lung Cancer (CTONG2203)一项以患者为中心、开放标签、多中心、II期研究，评估Lorlatinib单药疗法在局部晚期或转移性ALK阳性非小细胞肺癌患者一线治疗中的效果（CTONG2203）。Clinical Lung Cancer
OAAI
Clinical Lung CancerIF3.3
OAAI分享收藏Corrigendum to “Identifying cancer cachexia in patients without weight loss information: machine learning approaches to address a real-world challenge” Am J Clin Nutr 116 (2022) 1229–1239勘误：“Identifying cancer cachexia in patients without weight loss information: machine learning approaches to address a real-world challenge” Am J Clin Nutr 116 (2022) 1229–1239
PREAI
分享收藏